Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-10-04 Sale |
2023-10-06 7:19 pm |
Zentalis Pharmaceuticals Inc. | ZNTL | Brownstein Carrie Chief Medical Officer |
10,628 | $19.5 | $207,298 | 105,685 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-06-21 Option Award |
2024-06-21 5:59 pm |
N/A 2034-06-21 |
Shattuck Labs Inc. | STTK | Brownstein Carrie Director |
27,700 | $0 | 27,700 (Direct) |
View |
| 2023-05-26 Option Award |
2023-05-31 4:36 pm |
N/A 2033-05-26 |
Shattuck Labs Inc. | STTK | Brownstein Carrie Director |
40,258 | $0 | 40,258 (Direct) |
View |
| 2023-02-01 Option Award |
2023-02-01 7:06 pm |
N/A 2033-01-31 |
Zentalis Pharmaceuticals Inc. | ZNTL | Brownstein Carrie Chief Medical Officer |
40,000 | $0 | 140,000 (Direct) |
View |
| 2022-10-03 Option Award |
2022-10-03 6:37 pm |
N/A 2032-10-02 |
Zentalis Pharmaceuticals Inc. | ZNTL | Brownstein Carrie Chief Medical Officer |
400,000 | $0 | 500,000 (Direct) |
View |
| 2022-06-08 Option Award |
2022-06-10 4:31 pm |
N/A 2032-06-08 |
Shattuck Labs Inc. | STTK | Brownstein Carrie Director |
40,258 | $0 | 40,258 (Direct) |
View |
| 2021-11-12 Option Award |
2021-11-17 4:10 pm |
N/A 2031-11-12 |
Shattuck Labs Inc. | STTK | Brownstein Carrie Director |
10,467 | $0 | 10,467 (Direct) |
View |